TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20650377

Group type: EXPERIMENTAL
Intervention: Lidocaine with 0.5 mg neostigmine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lidocaine with isotonic saline
Number of subjects: 40
Study: 18757948

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 3146

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 3146
Study: 15977590

Group type: EXPERIMENTAL
Intervention: Intimate partner violence (any type)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Intimate partner violence (perpetration)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Sexual violence (experienced)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Physical, sexual, and psychological violence (perpetration)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Exposure to violence in family of origin
Number of subjects: 248
Study: 12873857

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride, 100 mg 3 times daily for 2 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Amantadine therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo phase
Number of subjects: 24
Study: 11429003

Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (2 g daily for 2-3 months) following 14-21 days of intravenous ganciclovir (5 mg/kg b.i.d.)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intravenous ganciclovir (5 mg/kg b.i.d. for 14-21 days)
Number of subjects: 37
Study: 8785142

Group type: EXPERIMENTAL
Intervention: Continuous non-invasive arterial pressure measurement (CNAP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oscillometric measurements
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CNAP during induction of anaesthesia
Number of subjects: 22
Study: 1998761

Group type: EXPERIMENTAL
Intervention: Perindopril 2‐8 mg daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nifedipine 20‐80 mg daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both drugs (Perindopril and Nifedipine)
Number of subjects: 50
Study: 6689152

Group type: EXPERIMENTAL
Intervention: Standard Pro‐Banthine 15 mg tablets
Number of subjects: 6

Group type: COMPARATOR
Intervention: Developmental PA Pro‐Banthine 45 mg capsule
Number of subjects: 6

Group type: COMPARATOR
Intervention: Two prolonged acting (PA) Pro‐Banthine 30 mg tablets
Number of subjects: 6
Study: 30841858

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg daily for six weeks
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 29559724

Group type: EXPERIMENTAL
Intervention: Individualised dietary advice (I)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Individualised dietary advice supplemented with 30 g walnuts/day (IW)
Number of subjects: 211

Group type: COMPARATOR
Intervention: General dietary advice (Control)
Number of subjects: 211
Study: 27998295

Group type: EXPERIMENTAL
Intervention: Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual Care followed by Delayed Treatment with TranS-C (UC-DT)
Number of subjects: 120
Study: 24381122

Group type: EXPERIMENTAL
Intervention: Prohormone (330 mg/day of 3β‐hydroxy‐5α‐androst‐1‐en‐17‐one)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (sugar)
Number of subjects: 17
Study: 22620717

Group type: EXPERIMENTAL
Intervention: Polidocanol (POL) 0.5% for telangiectasias
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Polidocanol (POL) 1% for reticular veins
Number of subjects: 63

Group type: COMPARATOR
Intervention: Hypertonic saline (HS) 11.7% for telangiectasias
Number of subjects: 63

Group type: COMPARATOR
Intervention: Hypertonic saline (HS) 23.4% for reticular veins
Number of subjects: 63
Study: 20107727

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 347

Group type: COMPARATOR
Intervention: Pimecrolimus cream
Number of subjects: 347
Study: 17327248

Group type: EXPERIMENTAL
Intervention: On-pump CABG technique
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Off-pump CABG technique
Number of subjects: 2200
Study: 15630027

Group type: EXPERIMENTAL
Intervention: Late gadolinium enhancement CMR in cardiac amyloidosis patients
Number of subjects: 30
Study: 14589725

Group type: EXPERIMENTAL
Intervention: Malingering conditions (malingerers, malingerers-with-warning)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonmalingering conditions (warning-only, control)
Number of subjects: 60
Study: 10210048

Group type: EXPERIMENTAL
Intervention: Sevoflurane (S group, n = 15) at a minimal concentration of 4% in oxygen for induction and at 0.5‐2 MAC end‐tidal concentration for maintenance.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Total intravenous technique (T group, n = 15) consisting of midazolam for induction and propofol for maintenance.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane/sufentanil maintenance
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol/sufentanil technique
Number of subjects: 30
Study: 7882465

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 21
Study: 3101812

Group type: EXPERIMENTAL
Intervention: Ultraviolet B phototherapy combined with dithranol using fluorescent lamps with negligible ultraviolet C emission (Wolff Helarium)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Medium pressure mercury arc lamp
Number of subjects: 24

Group type: COMPARATOR
Intervention: Array of fluorescent sunlamps
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dithranol alone
Number of subjects: 24
Study: 29265834

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: CBT for insomnia
Number of subjects: 188
Study: 28028369

Group type: EXPERIMENTAL
Intervention: Pegylated interferon α-2a (0.5 mg daily for 48 weeks)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Entecavir (0.5 mg daily for 48 weeks)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Pegylated interferon α-2a
Number of subjects: 88
Study: 25011430

Group type: EXPERIMENTAL
Intervention: Sport participation intervention in three regions of a Rotterdam youth care organization
Number of subjects: 2

Group type: COMPARATOR
Intervention: Care-as-usual in two control regions
Number of subjects: 2
Study: 22373031

Group type: EXPERIMENTAL
Intervention: Lentis Mplus MIOL
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acri.Lisa 366 MIOL
Number of subjects: 80

Group type: COMPARATOR
Intervention: Monofocal IOL (AR-40e) control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination of zonal refractive and diffractive aspheric MIOLs
Number of subjects: 80
Study: 20875522

Group type: EXPERIMENTAL
Intervention: Vibration frequency of 26Hz
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vibration frequency of 40Hz
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no vibration)
Number of subjects: 10
Study: 18622271

Group type: EXPERIMENTAL
Intervention: Outcomes research
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 0
Study: 19930883

Group type: EXPERIMENTAL
Intervention: UTI 8 kU/kg (group U1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: UTI 12 kU/kg (group U2)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 15860850

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 201
Study: 11315837

Group type: EXPERIMENTAL
Intervention: Metformin (1,500 mg daily orally)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: GLP-1 (continuous subcutaneous infusion of 2.4 pmol x kg(‐1) x min(‐1))
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combination therapy (metformin + GLP-1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: GLP-1
Number of subjects: 7
Study: 9006356

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Carbogen inhalation therapy
Number of subjects: 168
Study: 8390514

Group type: EXPERIMENTAL
Intervention: E + Stroop (60 min exercise at 60% maximal oxygen uptake followed by Stroop color word task)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Stroop (Stroop color word task without prior exercise)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ex (60 min exercise at 60% maximal oxygen uptake followed by 20 min seated recovery)
Number of subjects: 8
Study: 3684738

Group type: EXPERIMENTAL
Intervention: 150-watt xenon-arc solar simulator
Number of subjects: 0

Group type: COMPARATOR
Intervention: 300-watt Osram Ultravitalux bulbs
Number of subjects: 0
Study: 11323042

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for 70-99% stenosis
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for 50-69% stenosis
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for 65-74 years
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for less than 65 years
Number of subjects: 216

Group type: COMPARATOR
Intervention: Perioperative risk of stroke and death
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Number needed to treat
Number of subjects: 216
Study: 30540556

Group type: EXPERIMENTAL
Intervention: Rheo Knee XC
Number of subjects: 6

Group type: COMPARATOR
Intervention: C-Leg
Number of subjects: 6
Study: 30285042

Group type: EXPERIMENTAL
Intervention: 1.5 L of water daily (water group)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No additional fluids (control group)
Number of subjects: 140
Study: 27137175

Group type: EXPERIMENTAL
Intervention: Light intensity aerobic exercise (45' at 50% of maximum heart rate)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise (45' at 75% of maximum heart rate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (45' of rest)
Number of subjects: 20
Study: 25275613

Group type: EXPERIMENTAL
Intervention: First analgesic treatment with positive or negative experiences (details on dosage and duration not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second different analgesic treatment (details on dosage and duration not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychological trait variables (anxiety, depression, locus of control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neuroimaging data
Number of subjects: 0
Study: 21877951

Group type: EXPERIMENTAL
Intervention: 750 mg of dried rosemary leaf powder
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 6,000 mg of dried rosemary leaf powder
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 21203437

Group type: EXPERIMENTAL
Intervention: TIV + VAX102
Number of subjects: 80

Group type: COMPARATOR
Intervention: TIV + placebo
Number of subjects: 80
Study: 17083342

Group type: COMPARATOR
Intervention: Fludarabine
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Fludarabine plus cyclophosphamide (FC)
Number of subjects: 375
Study: 15034215

Group type: EXPERIMENTAL
Intervention: Raltitrexed 3 mg/m2 iv on day 1 and oxaliplatin 70 mg/m2 iv on day 1 and day 8 every 3 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Raltitrexed plus oxaliplatin regimen
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Side effects of the treatment
Number of subjects: 44
Study: 12466015

Group type: EXPERIMENTAL
Intervention: Low Sodium Treatment (LS: 143 10 mM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High Sodium Treatment (HS: 434+/‐17 mM Na+/d excreted)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Head Down Bed Rest (HDBR)
Number of subjects: 10
Study: 9660281

Group type: EXPERIMENTAL
Intervention: i.m. betamethasone
Number of subjects: 92

Group type: COMPARATOR
Intervention: i.m. placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: i.m. betamethasone (in patients with positive culture for streptococcus species)
Number of subjects: 92
Study: 7584191

Group type: EXPERIMENTAL
Intervention: Smoothing with a xenon chloride excimer laser in grade II chondromalacia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Debridement and lavage
Number of subjects: 0
Study: 2644051

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.04 mg.kg‐1 administered as a single bolus
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.01 mg.kg‐1 followed by 0.03 mg.kg‐1 after 3 min (priming)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No priming (control)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Priming with neostigmine
Number of subjects: 14
Study: 31992344

Group type: EXPERIMENTAL
Intervention: 10 kHz spinal cord stimulation plus usual care
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sham 10 kHz spinal cord stimulation plus usual care
Number of subjects: 96
Study: 28222548

Group type: EXPERIMENTAL
Intervention: Positive pressure body weight-supported treadmill training (BWSTT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Post-intervention overground walking assessments
Number of subjects: 20
Study: 26160208

Group type: EXPERIMENTAL
Intervention: SLC6A14 rs2312054 A allele carriers
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: SLC6A14 rs12391221 A allele carriers
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: SLC6A14 rs2071877 C allele carriers (boys)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: 5-HTR2C rs3813928 A allele carriers
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: 5-HTR2C rs3813929 T allele carriers
Number of subjects: 344
Study: 23253653

Group type: EXPERIMENTAL
Intervention: Motivational text messaging three times a day, 3 days a week, for 6 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no text messaging)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Motivational text messaging
Number of subjects: 36
Study: 21727148

Group type: EXPERIMENTAL
Intervention: Fingolimod 1.25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fingolimod 5.0 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18165571

Group type: EXPERIMENTAL
Intervention: Propofol and remifentanil target-controlled infusion with randomized remifentanil targets ranging from 2 to 8 ng/mL, with half receiving neuromuscular blockade.
Number of subjects: 105
Study: 16445497

Group type: EXPERIMENTAL
Intervention: Group A (density of melanocytes transplanted approximately 231.60+/‐ 27.03/mm(2))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group B (density of melanocytes transplanted approximately 154.90+/‐ 27.65/mm(2))
Number of subjects: 20
Study: 12628571

Group type: EXPERIMENTAL
Intervention: Cutout work surface
Number of subjects: 32

Group type: COMPARATOR
Intervention: Regular work surface
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Inclined desktop
Number of subjects: 32

Group type: COMPARATOR
Intervention: Horizontal desk
Number of subjects: 32
Study: 10472223

Group type: COMPARATOR
Intervention: Fentanyl 0 micrograms kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 microgram kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fentanyl 4 micrograms kg‐1
Number of subjects: 80
Study: 8709688

Group type: EXPERIMENTAL
Intervention: Single 1 g oral dose of ciprofloxacin
Number of subjects: 260

Group type: COMPARATOR
Intervention: Single 300 mg oral dose of doxycycline
Number of subjects: 260

Group type: COMPARATOR
Intervention: Single 300 mg oral dose of doxycycline (tetracycline-resistant strain)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Single 300 mg oral dose of doxycycline (tetracycline-susceptible strain)
Number of subjects: 260
Study: 2018224

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg of midazolam
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Alcohol (0.7 g/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No alcohol
Number of subjects: 16
Study: 6750325

Group type: EXPERIMENTAL
Intervention: graded sequential mestranol and norethisterone
Number of subjects: 23

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study: 31775152

Group type: COMPARATOR
Intervention: 0 ppm F dentifrice/gel (H0/L0)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 1,450 ppm F dentifrice/gel (H1,450/L1,450)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 5,000 ppm F dentifrice/gel (H5,000/L5,000)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 12,500 ppm F dentifrice/gel (H12,500/L12,500)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 5,000 ppm F plus TCP dentifrice/gel (H5,000+TCP/L5,000+TCP)
Number of subjects: 240
Study: 31441100

Group type: EXPERIMENTAL
Intervention: BRAVE program (8-week supervised exercise training)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual care (wait list control)
Number of subjects: 250
Study: 27566056

Group type: EXPERIMENTAL
Intervention: Simple snare papillectomy (SSP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Submucosal injection papillectomy (SIP)
Number of subjects: 50
Study: 27132416

Group type: EXPERIMENTAL
Intervention: GnRH analogue (single administration)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (single administration)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 51
Study: 25117004

Group type: EXPERIMENTAL
Intervention: Sleep deprivation group
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sleep group
Number of subjects: 37

Group type: COMPARATOR
Intervention: Day group
Number of subjects: 37
Study: 22869471

Group type: EXPERIMENTAL
Intervention: Primary spontaneous pneumothorax (PSP) group
Number of subjects: 234

Group type: COMPARATOR
Intervention: Normal volunteer group (no lung disease)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: PSP group
Number of subjects: 234

Group type: COMPARATOR
Intervention: Normal group
Number of subjects: 234
Study: 19056607

Group type: EXPERIMENTAL
Intervention: Threonine intake ranging from 10 to 100 mg . kg(‐1) . d(‐1)
Number of subjects: 9
Study: 17579202

Group type: EXPERIMENTAL
Intervention: recombinant human luteinizing hormone (rhLH)
Number of subjects: 15

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 15
Study: 15531971

Group type: EXPERIMENTAL
Intervention: 6‐TSM
Number of subjects: 17

Group type: COMPARATOR
Intervention: 3‐TTM
Number of subjects: 17
Study: 11584913

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg cortisol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 20
Study: 9444927

Group type: EXPERIMENTAL
Intervention: Surgical strategy involving biliary reconstruction after resection of extrahepatic bile ducts and gallbladder for PBM patients without CCD
Number of subjects: 0
Study: 8181883

Group type: EXPERIMENTAL
Intervention: Transdermal nitrate therapy (0.4 mg/h)
Number of subjects: 46
Study: 3356109

Group type: EXPERIMENTAL
Intervention: Aqueous aerosols with pH 2.6 and 10.0
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: D-glucose solutions (osmolarity range 77-1232 mosmol/l)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline solutions (osmolarity range 77-1232 mosmol/l)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isotonic and hypertonic mixtures of D-glucose and saline
Number of subjects: 21
Study: 31443941

Group type: EXPERIMENTAL
Intervention: Group D (90% length screws with a fractured lateral hinge)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group E (90% length screws with gap filling using a bone substitute)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group C (unicortically fixated: 55% of drilled tunnel length)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group A (bicortically fixated)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group B (unicortically fixated: 90% of drilled tunnel length)
Number of subjects: 40
Study: 28429906

Group type: EXPERIMENTAL
Intervention: Glutinous brown rice (GBR)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Non-glutinous brown rice (BR)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non-glutinous white rice (WR)
Number of subjects: 37
Study: 26749760

Group type: EXPERIMENTAL
Intervention: Nobecutan® plastic dressing spray applied directly on the wound
Number of subjects: 82

Group type: COMPARATOR
Intervention: No dressing spray applied (control group)
Number of subjects: 82
Study: 23957658

Group type: EXPERIMENTAL
Intervention: Generx (Ad5FGF4) administered via intracoronary route
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 21429975

Group type: EXPERIMENTAL
Intervention: Nurse home visiting programme
Number of subjects: 208

Group type: COMPARATOR
Intervention: Usual universal care
Number of subjects: 208
Study: 19187190

Group type: EXPERIMENTAL
Intervention: Haemophilia patients
Number of subjects: 83
Study: 17276647

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15258127

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) applied via large surface electrodes at an intensity sufficient to evoke 50% of maximal voluntary contraction (MVC) during an 80-Hz tetanus.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Transcutaneous stimulation (maximally to the femoral nerve).
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: P20 and P80 measurements.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: P20-P80 ratio measurement.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-to-high frequency ratio measurement.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Knee extensor MVC and voluntary activation level measurements.
Number of subjects: 20
Study: 11164665

Group type: EXPERIMENTAL
Intervention: Oxandrolone (anabolic steroid)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (optimum nutrition and exercise alone)
Number of subjects: 2
Study: 9333788

Group type: EXPERIMENTAL
Intervention: Theophylline chewable tablet (100 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Theophylline solution (reference)
Number of subjects: 14
Study: 8492277

Group type: EXPERIMENTAL
Intervention: Iron supplement (20 mg Fe) for 30 days
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Vermifuge treatment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 3124628

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0